Press Release

In Vitro Lung Model Market to Grow with a CAGR of 16.20% through 2030

Surge in research and development activities are the drivers for the Global In Vitro Lung Model Market in the forecast period 2026-2030. 


According to TechSci Research report, “In Vitro Lung Model Market– Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030F”, Global In Vitro Lung Model Market was valued at USD 402.43 Million in 2024 and will see a steady growth in the forecast period at a CAGR of 16.20% through 2030

Investment and funding play a critical role in supporting R&D initiatives focused on advancing the development and optimization of in vitro lung models. Research grants, government funding programs, and private investments offer financial backing to academic institutions, research organizations, and biotechnology companies, enabling them to conduct foundational and translational research in respiratory biology, tissue engineering, and drug discovery. These funding initiatives foster innovation, encourage collaboration, and expedite the translation of scientific breakthroughs into practical applications within the field of in vitro lung modeling.

                                                                                             

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global In Vitro Lung Model Market”

  

The Global In Vitro Lung Model Market is segmented into type, application, regional distribution, and company.

Based on Application, Drug Screening have emerged as the fastest growing segment in Global In Vitro Lung Model Market during the forecast period. Drug screening in the In Vitro Lung Model Market utilizes experimental systems that replicate key aspects of lung physiology and pathology to evaluate the efficacy, safety, and toxicity of pharmaceutical compounds. This process is essential in drug discovery, development, and regulatory approval, as it helps identify promising drug candidates, optimize formulations, and predict potential lung-related adverse effects. Lung cells, either primary cells from human donors or immortalized cell lines, are cultured and maintained in vitro under controlled conditions that mimic the natural environment of lung tissue. These cells may be cultured at an air-liquid interface (ALI) to replicate the conditions of the respiratory epithelium, promoting enhanced differentiation and functional maturation of lung cell types.

Based on region, Asia Pacific have emerged as the fastest growing region in the Global In Vitro Lung Model Market in 2024. Several countries in the Asia Pacific region, including China, India, Japan, and South Korea, are making significant investments in healthcare infrastructure and research. This growing expenditure is fueling advancements in technologies such as in vitro lung models. The rising prevalence of respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), and lung cancer, is driving the demand for more advanced research tools. Contributing factors such as air pollution, smoking, and shifting lifestyles are exacerbating respiratory conditions in the region. As a result, the need for innovative solutions like in vitro lung models for drug development and testing is becoming more critical. The Asia Pacific region is quickly embracing and advancing biomedical research, with universities, research institutes, and pharmaceutical companies investing in state-of-the-art technologies, including in vitro models, to accelerate drug discovery.


Major companies operating in Global In Vitro Lung Model Market are:

  • Epithelix Sarl
  • Mattek Corp.
  • Lonza Group AG
  • Emulate Inc.
  • AlveoliX AG
  • Nortis Inc.
  • CN Bio Innovations Ltd.
  • Mimetas BV
  • InSphero AG
  • ATTC Global

 

Download Free Sample Report

Customers can also request for 10% free customization on this report

 

Nanotechnology is playing a transformative role in the In Vitro Lung Model market by enabling the development of more accurate and functional models for studying lung diseases and testing drug efficacy. Through the application of nanomaterials, researchers can enhance the precision of in vitro models, allowing for better replication of the complex architecture and cellular interactions found in the human lung. This level of sophistication enhances the accuracy of disease modeling, such as for respiratory conditions like asthma, COPD, and lung cancer”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based Global management consulting firm.

In Vitro Lung Model Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (2D, 3D), By Application (Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, Regenerative Medicine), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of Global In Vitro Lung Model Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global In Vitro Lung Model Market.

 

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com

Relevant News